TARO Taro Pharmaceutical Industries Ltd
Taro Pharmaceutical Industries Ltd is a science-based pharmaceutical company. It develops, manufacture and market Rx and OTC (over-the-counter) pharmaceutical products primarily in the United States, Canada and Israel.
$34.23 -0.28 (-0.81%)
As of 08/12/2022 16:00:02 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Small cap
GICS sector: Health Care
Industry: Drug Manufacturers—Specialty &
Index country: Israel
Country of incorporation: Israel
IPO date: 02/11/2013
Outstanding shares: 37,584,631
Average volume: 19,585
Market cap: $1,286,521,919
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
Sedol: 2872423
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%